The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection

References

• Flexner S, Jobling JW. An analysis of four hundred cases of epidemic meningitis treated with the anti-meningitis serum. J Exp Med. 1908;10(5):690–733.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Meningococcal disease. In: Hamborsky J, Kroger A, Wolfe C, editors. Epidemiology and prevention of vaccine-preventable diseases. 13th ed. Washington, DC: Public Health Foundation; 2016.
   Google Scholar
• Manchanda V, Gupta S, Bhalla P. Meningococcal disease: history, epidemiology, pathogenesis, clinical manifestations, diagnosis, antimicrobial susceptibility and prevention. Indian J Med Microbiol. 2006;24(1):7–19.
   PubMedGoogle Scholar
• Abio A, Neal KR, Beck CR. An epidemiological review of changes in meningococcal biology during the last 100 years. Pathog Glob Health. 2013;107(7):373–380.
   PubMed Web of Science ®Google Scholar
• Al-Tawfiq JA, Clark TA, Memish ZA. Meningococcal disease: the organism, clinical presentation, and worldwide epidemiology. J Travel Med. 2010;17(Suppl):3–8.
   PubMed Web of Science ®Google Scholar
• Cartwright K, Noah N, Peltola H. Meningococcal disease in Europe: epidemiology, mortality, and prevention with conjugate vaccines. Report of a European advisory board meeting Vienna, Austria. Vaccine. 2000 [Oct 6-8];19(31):4347–4356.
   Google Scholar
• Pollard AJ. Global epidemiology of meningococcal disease and vaccine efficacy. Pediatr Infect Dis J. 2004;23(12 Suppl):S274–S279.
   PubMedGoogle Scholar
• Sáfadi MA, Barros AP. Meningococcal conjugate vaccines: efficacy and new combinations. J Pediatr (Rio J). 2006;82(3 Suppl):S35–S44.
   PubMedGoogle Scholar
• Stefanelli P, Rezza G. Impact of vaccination on meningococcal epidemiology. Hum Vaccin Immunother. 2016;12(4):1051–1055.
   PubMed Web of Science ®Google Scholar
• Pace D, Pollard AJ. Meningococcal disease: clinical presentation and sequelae. Vaccine. 2012;30(Suppl 2):B3–B9.
   PubMed Web of Science ®Google Scholar
• Harrison LH, Pelton SI, Wilder-Smith A, et al. The global meningococcal initiative: recommendations for reducing the global burden of meningococcal disease. Vaccine. 2011;29(18):3363–3371.
   PubMedGoogle Scholar
• National Advisory Committee on Immunization (NACI). An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS). Can Commun Dis Rep. 2009;35(ACS–3):1–40.
   Google Scholar
• Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005;54(RR–7):1–21.
   PubMedGoogle Scholar
• Cohn AC, MacNeil JR, Harrison LH, et al. Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. Clin Infect Dis. 2010;50(2):184–191.
   PubMed Web of Science ®Google Scholar
• Cordeiro SM, Neves AB, Ribeiro CT, et al. Hospital-based surveillance of meningococcal meningitis in Salvador, Brazil. Trans R Soc Trop Med Hyg. 2007;101(11):1147–1153.
   PubMed Web of Science ®Google Scholar
• Kimmel SR. Prevention of meningococcal disease. Am Fam Physician. 2005;72(10):2049–2056.
   PubMed Web of Science ®Google Scholar
• Yazdankhah SP, Caugant DA. Neisseria meningitidis: an overview of the carriage state. J Med Microbiol. 2004;53(Pt 9):821–832.
   PubMed Web of Science ®Google Scholar
• Christensen H, May M, Bowen L, et al. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(12):853–861.
   PubMed Web of Science ®Google Scholar
• Trotter CL, Greenwood BM. Meningococcal carriage in the African meningitis belt. Lancet Infect Dis. 2007;7(12):797–803.
   PubMed Web of Science ®Google Scholar
• Caugant DA, Maiden MC. Meningococcal carriage and disease–population biology and evolution. Vaccine. 2009;27(Suppl 2):B64–B70.
   PubMed Web of Science ®Google Scholar
• Read RC. Neisseria meningitidis; clones, carriage, and disease. Clin Microbiol Infect. 2014;20(5):391–395.
   PubMed Web of Science ®Google Scholar
• Halperin SA, Bettinger JA, Greenwood B, et al. The changing and dynamic epidemiology of meningococcal disease. Vaccine. 2012;30(Suppl 2):B26–B36.
   PubMed Web of Science ®Google Scholar
• Pizza M, Rappuoli R. Neisseria meningitidis: pathogenesis and immunity. Curr Opin Microbiol. 2015;23:68–72.
   PubMed Web of Science ®Google Scholar
• Murray RL, Britton J, Leonardi-Bee J. Second hand smoke exposure and the risk of invasive meningococcal disease in children: systematic review and meta-analysis. BMC Public Health. 2012;12:1062.
   PubMed Web of Science ®Google Scholar
• Chang Q, Tzeng YL, Stephens DS. Meningococcal disease: changes in epidemiology and prevention. Clin Epidemiol. 2012;4:237–245.
   PubMedGoogle Scholar
• Centers for Disease Control and prevention website [Internet]. Advisory Committee on Immunization Practices. Vaccine acronyms: vaccines included in the immunization schedules for children, adolescents, and adults. [ cited 2015 May]. Available from: http://www.cdc.gov/vaccines/acip/committee/guidance/vac-abbrev.pdf
   Google Scholar
• Holst J, Oster P, Arnold R, et al. Vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV): lessons from past programs and implications for the future. Hum Vaccin Immunother. 2013;9(6):1241–1253.
   PubMed Web of Science ®Google Scholar
• Folaranmi T, Rubin L, Martin SW, et al. Use of serogroup B meningococcal vaccines in persons aged ≥10 years at Increased risk for serogroup B meningococcal disease: recommendations of the advisory committee on immunization practices, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(22):608–612.
   PubMed Web of Science ®Google Scholar
• MacNeil JR, Rubin L, Folaranmi T, et al. Use of serogroup B meningococcal vaccines in adolescents and young adults: recommendations of the advisory committee on immunization practices, 2015. MMWR Morb Mortal Wkly Rep. 2015;64(41):1171–1176.
   PubMed Web of Science ®Google Scholar
• John TJ, Gupta S, Chitkara AJ, et al. An overview of meningococcal disease in India: knowledge gaps and potential solutions. Vaccine. 2013;31(25):2731–2737.
   PubMed Web of Science ®Google Scholar
• Sáfadi MA, de los Monteros LE, López EL, et al. The current situation of meningococcal disease in Latin America and recommendations for a new case definition from the Global Meningococcal Initiative. Expert Rev Vaccines. 2013;12(8):903–915.
   PubMed Web of Science ®Google Scholar
• Sáfadi MA, Bettinger JA, Maturana GM, et al. Evolving meningococcal immunization strategies. Expert Rev Vaccines. 2015;14(4):505–517.
   PubMed Web of Science ®Google Scholar
• Sáfadi MA, O’Ryan M, Valenzuela Bravo MT, et al. The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations. Vaccine. 2015;33(48):6529–6536.
   PubMed Web of Science ®Google Scholar
• Vázquez JA, Taha MK, Findlow J, et al. Global Meningococcal Initiative: guidelines for diagnosis and confirmation of invasive meningococcal disease. Epidemiol Infect. 2016;144(14):3052–3057.
   PubMed Web of Science ®Google Scholar
• Lucidarme J, Hill DM, Bratcher HB, et al. Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage. J Infect. 2015;71(5):544–552.
   PubMed Web of Science ®Google Scholar
• Sáfadi MA, Berezin EN, Arlant LH. Meningococcal disease: epidemiology and early effects of immunization programs. J Pediatric Infect Dis Soc. 2014;3(2):91–93.
   PubMedGoogle Scholar
• de Moraes JC, Kemp B, de Lemos APS, et al. Prevalence, risk factors and molecular characteristics of meningococcal carriage among Brazilian adolescents. Pediatr Infect Dis J. 2015;34(11):1197–1202.
   PubMed Web of Science ®Google Scholar
• Sáfadi MA, Carvalhanas TR, Paula de Lemos A, et al. Carriage rate and effects of vaccination after outbreaks of serogroup C meningococcal disease, Brazil, 2010. Emerg Infect Dis. 2014;20(5):806–811.
   PubMed Web of Science ®Google Scholar
• World Population Statistics website [Internet]. World Population Statistics. Population of Asia. 2016. [cited 2016 Jan]. Available from: http://www.worldpopulationstatistics.com/population-of-asia/
   Google Scholar
• World Population Statistics website [Internet]. World Health Organization. WHO regional offices. [ cited 2016]. Available from: http://www.who.int/about/regions/en/
   Google Scholar
• Jafri RZ, Ali A, Messonnier NE, et al. Global epidemiology of invasive meningococcal disease. Popul Health Metr. 2013;11(1):17.
   PubMed Web of Science ®Google Scholar
• Borrow R, Lee JS, Vázquez JA, et al. Meningococcal disease in the Asia-Pacific region: Findings and recommendations from the Global Meningococcal Initiative. Vaccine. 2016;34(48):5855–5862.
   Google Scholar
• World Health Organization website [Internet]. World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2016 global summary. [ cited 2016 Jul]. Available from: http://apps.who.int/immunization_monitoring/globalsummary.
   Google Scholar
• World Health Organization Western Pacific Region website [Internet]. World Health Organization Western Pacific Region. China, 2014. [cited 2015]. Available from: http://www.wpro.who.int/immunization/documents/epi_country_poster_2014_chn.pdf.
   Google Scholar
• Australian Government Department of Health website [Internet]. Australian Government Department of Health. National immunisation program schedule. [ cited 2016 Sep]. Available from: http://www.immunise.health.gov.au/internet/immunise/publishing.nsf/Content/nips.
   Google Scholar
• Tanaka H, Kuroki T, Watanabe Y, et al. Isolation of Neisseria meningitidis from healthy persons in Japan. Kansenshogaku. Zasshi. 2005;79(8):527–533.
   PubMedGoogle Scholar
• Takahashi H, Haga M, Sunagawa T, et al. Meningococcal carriage rates in healthy individuals in Japan determined using loop-mediated isothermal amplification and oral throat wash specimens. J Infect Chemother. 2016;22(7):501–504.
   PubMed Web of Science ®Google Scholar
• Hamada A, Fukushima S. Present situation and challenges of vaccinations for overseas travelers from Japan. J Infect Chemother. 2015;21(6):405–409.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Surveillance of invasive bacterial diseases in Europe, 2012. Stockholm: ECDC; 2015.
   Google Scholar
• Borrow R, Abad R, Trotter C, et al. Effectiveness of meningococcal serogroup C vaccine programmes. Vaccine. 2013;31(41):4477–4486.
   PubMed Web of Science ®Google Scholar
• Koroleva I. Meningococcal infection and purulent bacterial meningitis in Russia: analytical review. Moscow: Central Research Institute of Epidemiology, Russian Inspectorate for the Protection of Consumer Rights and Human Welfare; 2014.
   Google Scholar
• Matosova SV, Mironov KO, Platonov AE, et al. Molecular biological monitoring of Neisseria meningitidis in Moscow in the period 2011 to 2015. Epidemiologia I Infekcionnye Bolezni. 2016;2:4–9.
   Google Scholar
• Meiring S, Cohen C, de Gouveia L et al. A decade of invasive meningococcal disease surveillance in South Africa: 2003–2012. The 16th International Congress on Infectious Diseases (ICID); Apr 2-5, 2014, Cape Town, South Africa.
   Google Scholar
• von Gottberg A, du Plessis M, Cohen C, et al. Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. Clin Infect Dis. 2008;46(3):377–386.
   PubMed Web of Science ®Google Scholar
• Cohen C, Singh E, Wu HM, et al. Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa. AIDS. 2010;24(9):1351–1360.
   PubMed Web of Science ®Google Scholar
• Simmons RD, Kirwan P, Beebeejaun K, et al. Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study. BMC Med. 2015;13:297.
   PubMed Web of Science ®Google Scholar
• Ibarz-Pavón AB, Morais L, Sigaúque B et al. Epidemiology, molecular characterization and antibiotic resistance of Neisseria meningitidis from patients ≤15 years in Manhiça, rural Mozambique. PLoS One. 2011;6:(6), e19717.
   PubMed Web of Science ®Google Scholar
• Murray J, Agocs M, Serhan F, et al. Global invasive bacterial vaccine-preventable diseases surveillance–2008-2014. MMWR Morb Mortal Wkly Rep. 2014;63(49):1159–1162.
   PubMed Web of Science ®Google Scholar
• Baccarini C, Ternouth A, Wieffer H, et al. The changing epidemiology of meningococcal disease in North America 1945-2010. Hum Vaccin Immunother. 2013;9(1):162–171.
   PubMed Web of Science ®Google Scholar
• Government of Canada website [Internet]. Public Health Agency of Canada. Canadian immunization guide. [cited 2016 Feb]. Available from: http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-meni-eng.php
   Google Scholar
• Maiden MC, Ibarz-Pavon AB, Urwin R, et al. Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis. 2008;197(5):737–743.
   PubMed Web of Science ®Google Scholar
• Ramsay ME, Andrews NJ, Trotter CL, et al. Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. Bmj. 2003;326(7385):365–366.
   PubMed Web of Science ®Google Scholar
• GOV UK website [Internet]. Public Health England. Meningococcal meningitis and septicaemia notifiable. [ cited 2015 Sep]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/462629/2904512_Green_Book_Chapter_22_v6_0W.PDF
   Google Scholar
• Kristiansen PA, Diomande F, Ba AK, et al. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clin Infect Dis. 2013;56(3):354–363.
   PubMed Web of Science ®Google Scholar
• Daugla DM, Gami JP, Gamougam K, et al. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study [corrected]. Lancet. 2014;383(9911):40–47.
   PubMed Web of Science ®Google Scholar
• Jeppesen CA, Snape MD, Robinson H, et al. Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy. J Infect. 2015;71(1):43–52.
   PubMed Web of Science ®Google Scholar
• Caugant DA, Kristiansen PA, Wang X, et al. Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine. PLoS One. 2012;7(9):e46019.
   PubMed Web of Science ®Google Scholar
• Kretz CB, Retchless AC, Sidikou F, et al. Whole-genome characterization of epidemic neisseria meningitidis serogroup C and resurgence of serogroup W, Niger, 2015. Emerg Infect Dis. 2016;22(10):1762–1768.
   PubMed Web of Science ®Google Scholar
• Meningitis Vaccine Project website [Internet]. PATH. A public health breakthrough. [ cited 2015]. Available from: http://www.meningvax.org/
   Google Scholar
• World Health Organization website [Internet]. World Health Organization. WHO meningococcal meningitis. Fact sheet 141. [ cited 2015 Nov]. Available from: http://www.who.int/mediacentre/factsheets/fs141/en/
   Google Scholar
• Lingani C, Bergeron-Caron C, Stuart JM, et al. Meningococcal meningitis surveillance in the African meningitis belt, 2004-2013. Clin Infect Dis. 2015;61(Suppl 5):S410–S415.
   PubMed Web of Science ®Google Scholar
• Karachaliou A, Conlan AJ, Preziosi MP, et al. Modeling long-term vaccination strategies with MenAfriVac in the African meningitis belt. Clin Infect Dis. 2015;61(Suppl 5):S594–S600.
   PubMed Web of Science ®Google Scholar
• Global Advisory Committee on Vaccine Safety. 3-4 December 2009. Wkly Epidemiol Rec. 2010;85(5):29–33.
   PubMedGoogle Scholar
• World Health Organization website [Internet]. World Health Organization. Affordable and effective vaccine brings Africa close to elimination of meningitis A. [ cited 2015 Nov]. Available from: http://www.who.int/features/2015/meningitis-africa-elimination/en/
   Google Scholar
• World Health Organization website [Internet]. World Health Organization. Meningococcal disease: 2013 epidemic season in the African Meningitis Belt. [cited 2016 November]. Available from: http://www.who.int/csr/don/2013_06_06_menin/en/.
   Google Scholar
• Meningitis Vaccine Project website [Internet]. PATH. WHO surveillance bulletins. [ cited 2016]. Available from: http://www.meningvax.org/epidemic-updates.php.
   Google Scholar
• World Health Organization. Meningococcal disease control in countries of the African meningitis belt, 2014. Wkly Epidemiol Rec. 2015;90(13):123–131.
   PubMedGoogle Scholar
• World Health Organization website [Internet]. World Health Organization Strategic Advisory Group of Experts (SAGE) on Immunization. SAGE; 2014 Oct. [cited 2014 Oct]. Geneva: World Health Organization. Available from http://www.who.int/immunization/sage/meetings/2014/october/Yellow-bookSAGE2014_final.pdf
   Google Scholar
• World Health Organization website [Internet]. World Health Organization. Serogroup C in the meningitis belt: facing the challenge. Report of meeting held in Geneva, October 2015. [cited 2015 Nov]. Available from: http://www.who.int/csr/disease/meningococcal/Facing_NmC_Epidemics_Meningitis_Belt.pdf
   Google Scholar
• World Health Organization. Preparedness for outbreaks of meningococcal meningitis due to Neisseria meningitidis serogroup C in Africa: recommendations from a WHO expert consultation. Wkly Epidemiol Rec. 2015;90(47):633–636.
   PubMedGoogle Scholar
• Funk A, Uadiale K, Kamau C, et al. Sequential outbreaks due to a new strain of Neisseria meningitidis serogroup C in northern Nigeria, 2013-14. PLoS Curr. 2014;6. doi:10.1371/currents.outbreaks.b50c2aaf1032b3ccade0fca0b63ee518.
   PubMedGoogle Scholar
• Taha MK, Achtman M, Alonso JM, et al. Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet. 2000;356(9248):2159.
   PubMed Web of Science ®Google Scholar
• Taha MK, Parent Du Chatelet I, Schlumberger M, et al. Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger. J Clin Microbiol. 2002;40(3):1083–1084.
   PubMed Web of Science ®Google Scholar
• Mayer LW, Reeves MW, Al-Hamdan N, et al. Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. J Infect Dis. 2002;185(11):1596–1605.
   PubMed Web of Science ®Google Scholar
• Ferreira E, Dias R, Giorgini D, et al. Neisseria meningitidis serogroup W135 in Portugal: presence of the ST-11/ET-37 clonal complex. Pathol Biol (Paris). 2008;56(2):94–96.
   PubMed Web of Science ®Google Scholar
• Lemos AP, Harrison LH, Lenser M, et al. Phenotypic and molecular characterization of invasive serogroup W135 Neisseria meningitidis strains from 1990 to 2005 in Brazil. J Infect. 2010;60(3):209–217.
   PubMed Web of Science ®Google Scholar
• National Institute of Infectious Diseases website [Internet]. Kanai M, Hachisu Y, Fukusumi M et al. Meningococcal disease cases in Scotland and Sweden, following attendance at the World Scout Jamboree, Yamaguchi, Japan, July 28-August 8, 2015. [ cited 2015 Aug]. Available from: http://www.nih.go.jp/niid/en/id/997-disease-based/sa/bac-%20%20%20%20megingitis/idsc/iasr-in/5879-pr4272e.html
   Google Scholar
• Weidlich L, Baethgen LF, Mayer LW, et al. High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W135:P1.5,2:ST-11clone in Southern Brazil. J Infect. 2008;57(4):324–331.
   PubMed Web of Science ®Google Scholar
• Valenzuela MT, Moreno G, Vaquero A, et al. [Emergence of W135 meningococcal serogroup in Chile during 2012]. Rev Med Chil. 2013;141(8):959–967.
   PubMed Web of Science ®Google Scholar
• Abad R, Lopez EL, Debbag R, et al. Serogroup W meningococcal disease: global spread and current affect on the Southern Cone in Latin America. Epidemiol Infect. 2014;142(12):2461–2470.
   PubMed Web of Science ®Google Scholar
• Mustapha MM, Marsh JW, Krauland MG, et al. Genomic epidemiology of hypervirulent serogroup W, ST-11 Neisseria meningitidis. EBioMedicine. 2015;2(10):1447–1455.
   PubMed Web of Science ®Google Scholar
• LinkedIn SlideShare website [Internet]. Sáfadi MA. Emergence of a new virulent meningicoccal W sequence type 11 in South America: experience, control measures and impact. [ cited 2015 Nov]. Available from: http://www.slideshare.net/meningitis/dr-marco-safadi-mrfs-meningitis-septicaemia-in-children-adults-2015
   Google Scholar
• Ladhani SN, Beebeejaun K, Lucidarme J, et al. Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and wales. Clin Infect Dis. 2015;60(4):578–585.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Esposito S, Prymula R, et al. Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials. Lancet. 2013;381(9869):825–835.
   PubMed Web of Science ®Google Scholar
• FDA website [Internet]. US Food and Drug Administration. FDA News Release: FDA approves a second vaccine to prevent serogroup B meningococcal disease. [ cited 2015 Jan]. Available from: http://www.fda.gov/newsevents/newsroom/pressannouncements/ucm431370.htm
   Google Scholar
• European Medicine Agency website [Internet]. European Medicines Agency. Summary of the European public assessment report (EPAR) for Bexsero. [ cited 2015 Mar]. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002333/human_med_001614.jsp&mid=WC0b01ac058001d124
   Google Scholar
• Shirley M, Dhillon S. Bivalent rLP2086 vaccine (Trumenba®): a review in active immunization against invasive meningococcal group B disease in individuals aged 10-25 years. BioDrugs. 2015;29(5):353–361.
   PubMed Web of Science ®Google Scholar
• FDA website [Internet]. US Food and Drug Administration. FDA News Release: First vaccine approved by FDA to prevent serogroup B meningococcal disease. [ cited 2014 Oct]. Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm420998.htm.
   Google Scholar
• Donnelly J, Medini D, Boccadifuoco G, et al. Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines. Proc Natl Acad Sci U S A. 2010;107(45):19490–19495.
   PubMed Web of Science ®Google Scholar
• Hong E, Giuliani MM, Deghmane AE, et al. Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa? Vaccine. 2013;31(7):1113–1116.
   PubMed Web of Science ®Google Scholar
• Patel M. Use of a novel serogroup B meningococcal vaccine in response to two university outbreaks in the US. XIXth International Pathogenic Neisseria Conference; 2014 Oct 12-17; Asheville, NC, USA.
   Google Scholar
• McNamara LA, Shumate AM, Johnsen P, et al. First use of a serogroup B meningococcal vaccine in the US in response to a university outbreak. Pediatrics. 2015;135(5):798–804.
   PubMed Web of Science ®Google Scholar
• Medini D, Stella M, Wassil J. MATS: global coverage estimates for 4CMenB, a novel multicomponent meningococcal B vaccine. Vaccine. 2015;33(23):2629–2636.
   PubMed Web of Science ®Google Scholar
• GOV UK website [Internet]. Public Health England. National enhanced surveillance of vaccination programmes targeting invasive meningococcal disease in England. [cited 2015 Sep]. Available from: https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/457723/MeningoEnhancedSurveillancePlan_01092015_v1.1.pdf
   Google Scholar
• INSPQ website [Internet]. Institut National de Santé Publique Québec. Rapport intérimaire de surveillance de la sécurité de la première dose du vaccin contre le méningocoque de sérogroupe B au Saguenay-Lac-Saint-Jean. [cited 2014 Sep]. Available from: https://www.inspq.qc.ca/publications/1885
   Google Scholar
• INSPQ website [Internet]. Institut National de Santé Publique Québec. Avis sur la pertinence d’une intervention visant à contrôler une incidence élevée d’infections invasives à méningocoque de sérogroupe B dans l’Est du Québec. [cited 2014 Apr]. Available from: https://www.inspq.qc.ca/publications/1801
   Google Scholar
• Law DK, Lefebvre B, Gilca R, et al. Characterization of invasive Neisseria meningitidis strains from Quebec, Canada, during a period of increased serogroup B disease, 2009-2013: phenotyping and genotyping with special emphasis on the non-carbohydrate protein vaccine targets. BMC Microbiol. 2015;15:143.
   PubMed Web of Science ®Google Scholar
• Pan_Canadian Public Health Network website [Internet]. Meningococcal B Pilot Project Task Group. The recommended use of the multicomponent meningococcal B (4CMenB) vaccine in Canada. [ cited 2014 Mar]. Available from: http://publications.gc.ca/collections/collection_2014/aspc-phac/HP40-103-2014-eng.pdf
   Google Scholar
• Government of Canada website [Internet]. Public Health Agency of Canada. Advice for the use of the multicomponent meningococcal serogroup B (4CMenB) vaccine. [ cited 2014 Apr]. Available from: http://publications.gc.ca/site/eng/463960/publication.html
   Google Scholar
• de Wals P. Results of a mass immunization campaign with a 4-components serogroup B meningococcal vaccine in Quebec, Canada. Rio de Janeiro, Brazil: World Society for Pediatric Infectious Diseases; 2015 Nov 18-21.
   Google Scholar
• Delbos V, Lemee L, Benichou J, et al. Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage. Vaccine. 2013;31(40):4416–4420.
   PubMed Web of Science ®Google Scholar
• Meningitis Research Foundation website [Internet]. Meningitis Research Foundation. MenB. [ cited 2015]. Available from: http://www.meningitis.org/menb.
   Google Scholar
• Confederation of Meningitis Organisations website [Internet]. Confederation of Meningitis Organisations. About us. [ cited 2016]. Available from: http://www.comomeningitis.org/about-us/
   Google Scholar
• Confereration of Meningitis Organisations website [Internet]. Confederation of Meningitis Organisations. World Meningitis Day 2015. [cited 2015 May]. Available from: http://www.comomeningitis.org/news-and-events/world-meningitis-day/wmd-2015/
   Google Scholar
• Confederation of Meningitis Organisations website [Internet]. Booy R, Robinson P, Gold R, et al. The meningitis B debate. [ cited 2015 Sep]. Available from: http://www.comomeningitis.org/blog/2015/09/the-meningococcal-b-vaccine-debate/
   Google Scholar
• Trotter CL, Edmunds WJ. Reassessing the cost-effectiveness of meningococcal serogroup C conjugate (MCC) vaccines using a transmission dynamic model. Med Decis Making. 2006;26(1):38–47.
   PubMed Web of Science ®Google Scholar
• Read RC, Baxter D, Chadwick DR, et al. Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial. Lancet. 2014;384(9960):2123–2131.
   PubMed Web of Science ®Google Scholar
• Trotter CL, Gay NJ, Edmunds WJ. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am J Epidemiol. 2005;162(1):89–100.
   PubMed Web of Science ®Google Scholar
• Christensen H, Hickman M, Edmunds WJ, et al. Introducing vaccination against serogroup B meningococcal disease: an economic and mathematical modelling study of potential impact. Vaccine. 2013;31(23):2638–2646.
   PubMed Web of Science ®Google Scholar
• Mustapha MM, Marsh JW, Harrison LH. Global epidemiology of capsular group W meningococcal disease (1970-2015): multifocal emergence and persistence of hypervirulent sequence type (ST)-11 clonal complex. Vaccine. 2016;34(13):1515–1523.
   PubMed Web of Science ®Google Scholar
• Trotter CL, Maiden MC. Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs. Expert Rev Vaccines. 2009;8(7):851–861.
   PubMed Web of Science ®Google Scholar
• Taha MK, Claus H, Lappann M, et al. Evolutionary events associated with an outbreak of meningococcal disease in men who have sex with men. PLoS One. 2016;11(5):e0154047.
   PubMed Web of Science ®Google Scholar